Similar articles

• New perspectives in cardiopulmonary therapeutics: receptor-selective adrenergic drugs.

  Adams HR. Adams HR. J Am Vet Med Assoc. 1984 Nov 1;185(9):966-74. J Am Vet Med Assoc. 1984. PMID: 6150925 Review.
• Alpha 1- and alpha 2-adrenoceptors: pharmacology and clinical implications.

  Starke K, Docherty JR. Starke K, et al. J Cardiovasc Pharmacol. 1981;3 Suppl 1:S14-23. J Cardiovasc Pharmacol. 1981. PMID: 6169956 Review. No abstract available.
• [Therapeutic use of agents acting on alpha and beta receptors].

  Soballa G. Soballa G. Fortschr Med. 1974 Apr 18;92(11):461-6. Fortschr Med. 1974. PMID: 4150787 German. No abstract available.
• [Experimental pharmacological regulation of myocardial adrenoreceptors by agonists and concomitant catecholamine damage to the heart muscle].

  Sysoliatina NA. Sysoliatina NA. Farmakol Toksikol. 1987 Jul-Aug;50(4):106-11. Farmakol Toksikol. 1987. PMID: 2822472 Review. Russian. No abstract available.
• Inosine as a cardiotonic agent that reverses adrenergic beta blockade.

  Juhász-Nagy A, Aviado DM. Juhász-Nagy A, et al. J Pharmacol Exp Ther. 1977 Sep;202(3):683-95. J Pharmacol Exp Ther. 1977. PMID: 197230 No abstract available.